Goldman Sachs Group Inc Exact Sciences Corp Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Exact Sciences Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,088,843 shares of EXAS stock, worth $61.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,088,843
Previous 1,067,073 2.04%
Holding current value
$61.1 Million
Previous $45.1 Million 64.45%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$42.43 - $70.83 $923,701 - $1.54 Million
21,770 Added 2.04%
1,088,843 $74.1 Million
Q2 2024

Aug 13, 2024
BUY
$41.33 - $74.26 $4.82 Million - $8.65 Million
116,536 Added 12.26%
1,067,073 $45.1 Million
Q1 2024

May 15, 2024
BUY
$56.27 - $73.77 $1.96 Million - $2.57 Million
34,772 Added 3.8%
950,537 $65.6 Million
Q4 2023

Feb 13, 2024
SELL
$59.06 - $75.72 $563,078 - $721,914
-9,534 Reduced 1.03%
915,765 $67.7 Million
Q3 2023

May 14, 2024
BUY
$65.94 - $99.04 $628,671 - $944,247
9,534 Added 1.04%
925,299 $63.1 Million
Q3 2023

Nov 14, 2023
BUY
$65.94 - $99.04 $14 Million - $21 Million
212,526 Added 29.82%
925,299 $63.1 Million
Q2 2023

May 14, 2024
BUY
$62.68 - $95.05 $23.7 Million - $35.9 Million
377,676 Added 112.71%
712,773 $66.9 Million
Q2 2023

Aug 14, 2023
BUY
$62.68 - $95.05 $23.7 Million - $35.9 Million
377,676 Added 112.71%
712,773 $66.9 Million
Q1 2023

May 14, 2024
SELL
$47.19 - $70.77 $37.6 Million - $56.4 Million
-797,527 Reduced 70.41%
335,097 $22.7 Million
Q1 2023

May 11, 2023
SELL
$47.19 - $70.77 $37.6 Million - $56.4 Million
-797,527 Reduced 70.41%
335,097 $22.7 Million
Q4 2022

May 14, 2024
BUY
$30.35 - $53.15 $4.31 Million - $7.55 Million
142,032 Added 14.34%
1,132,624 $56.1 Million
Q4 2022

Feb 13, 2023
BUY
$30.35 - $53.15 $4.31 Million - $7.55 Million
142,032 Added 14.34%
1,132,624 $56.1 Million
Q3 2022

May 14, 2024
SELL
$31.97 - $49.37 $15.7 Million - $24.3 Million
-491,258 Reduced 33.15%
990,592 $32.2 Million
Q3 2022

Nov 10, 2022
SELL
$31.97 - $49.37 $15.7 Million - $24.3 Million
-491,258 Reduced 33.15%
990,592 $32.2 Million
Q2 2022

May 14, 2024
BUY
$35.61 - $76.23 $20.2 Million - $43.2 Million
566,085 Added 61.82%
1,481,850 $58.4 Million
Q2 2022

Aug 15, 2022
BUY
$35.61 - $76.23 $13.8 Million - $29.6 Million
388,740 Added 35.56%
1,481,850 $58.4 Million
Q1 2022

May 16, 2022
SELL
$57.56 - $82.54 $12.2 Million - $17.5 Million
-211,642 Reduced 16.22%
1,093,110 $76.4 Million
Q4 2021

Feb 14, 2022
BUY
$72.5 - $100.68 $53.9 Million - $74.9 Million
743,774 Added 132.59%
1,304,752 $102 Million
Q3 2021

Nov 10, 2021
BUY
$90.24 - $124.05 $50.6 Million - $69.6 Million
560,978 New
560,978 $53.5 Million

Others Institutions Holding EXAS

# of Institutions
673
Shares Held
162M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.93B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email